Cargando…

Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1

African horse sickness (AHS) is a highly infectious and often fatal disease caused by 9 serotypes of the orbivirus African horse sickness virus (AHSV). In March 2020, an AHS outbreak was reported in Thailand in which AHSV serotype 1 was identified as the causative agent. Trivalent live attenuated va...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yifan, Ong, Jasmine, Ng, Oi Wing, Songkasupa, Tapanut, Koh, Eileen Y., Wong, Jeslyn P.S., Puangjinda, Kanokwan, Fernandez, Charlene Judith, Huangfu, Taoqi, Ng, Lee Ching, Chang, Siow Foong, Yap, Him Hoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707579/
https://www.ncbi.nlm.nih.gov/pubmed/36417933
http://dx.doi.org/10.3201/eid2812.220594
_version_ 1784840730505641984
author Wang, Yifan
Ong, Jasmine
Ng, Oi Wing
Songkasupa, Tapanut
Koh, Eileen Y.
Wong, Jeslyn P.S.
Puangjinda, Kanokwan
Fernandez, Charlene Judith
Huangfu, Taoqi
Ng, Lee Ching
Chang, Siow Foong
Yap, Him Hoo
author_facet Wang, Yifan
Ong, Jasmine
Ng, Oi Wing
Songkasupa, Tapanut
Koh, Eileen Y.
Wong, Jeslyn P.S.
Puangjinda, Kanokwan
Fernandez, Charlene Judith
Huangfu, Taoqi
Ng, Lee Ching
Chang, Siow Foong
Yap, Him Hoo
author_sort Wang, Yifan
collection PubMed
description African horse sickness (AHS) is a highly infectious and often fatal disease caused by 9 serotypes of the orbivirus African horse sickness virus (AHSV). In March 2020, an AHS outbreak was reported in Thailand in which AHSV serotype 1 was identified as the causative agent. Trivalent live attenuated vaccines serotype 1, 3, and 4 were used in a targeted vaccination campaign within a 50-km radius surrounding the infected cases, which promptly controlled the spread of the disease. However, AHS-like symptoms in vaccinated horses required laboratory diagnostic methods to differentiate infected horses from vaccinated horses, especially for postvaccination surveillance. We describe a real-time reverse transcription PCR–based assay for rapid characterization of the affecting field strain. The development and validation of this assay should imbue confidence in differentiating AHS-vaccinated horses from nonvaccinated horses. This method should be applied to determining the epidemiology of AHSV in future outbreaks.
format Online
Article
Text
id pubmed-9707579
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-97075792022-12-09 Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1 Wang, Yifan Ong, Jasmine Ng, Oi Wing Songkasupa, Tapanut Koh, Eileen Y. Wong, Jeslyn P.S. Puangjinda, Kanokwan Fernandez, Charlene Judith Huangfu, Taoqi Ng, Lee Ching Chang, Siow Foong Yap, Him Hoo Emerg Infect Dis Research African horse sickness (AHS) is a highly infectious and often fatal disease caused by 9 serotypes of the orbivirus African horse sickness virus (AHSV). In March 2020, an AHS outbreak was reported in Thailand in which AHSV serotype 1 was identified as the causative agent. Trivalent live attenuated vaccines serotype 1, 3, and 4 were used in a targeted vaccination campaign within a 50-km radius surrounding the infected cases, which promptly controlled the spread of the disease. However, AHS-like symptoms in vaccinated horses required laboratory diagnostic methods to differentiate infected horses from vaccinated horses, especially for postvaccination surveillance. We describe a real-time reverse transcription PCR–based assay for rapid characterization of the affecting field strain. The development and validation of this assay should imbue confidence in differentiating AHS-vaccinated horses from nonvaccinated horses. This method should be applied to determining the epidemiology of AHSV in future outbreaks. Centers for Disease Control and Prevention 2022-12 /pmc/articles/PMC9707579/ /pubmed/36417933 http://dx.doi.org/10.3201/eid2812.220594 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Wang, Yifan
Ong, Jasmine
Ng, Oi Wing
Songkasupa, Tapanut
Koh, Eileen Y.
Wong, Jeslyn P.S.
Puangjinda, Kanokwan
Fernandez, Charlene Judith
Huangfu, Taoqi
Ng, Lee Ching
Chang, Siow Foong
Yap, Him Hoo
Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1
title Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1
title_full Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1
title_fullStr Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1
title_full_unstemmed Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1
title_short Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1
title_sort development of differentiating infected from vaccinated animals (diva) real-time pcr for african horse sickness virus serotype 1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707579/
https://www.ncbi.nlm.nih.gov/pubmed/36417933
http://dx.doi.org/10.3201/eid2812.220594
work_keys_str_mv AT wangyifan developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT ongjasmine developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT ngoiwing developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT songkasupatapanut developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT koheileeny developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT wongjeslynps developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT puangjindakanokwan developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT fernandezcharlenejudith developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT huangfutaoqi developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT ngleeching developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT changsiowfoong developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1
AT yaphimhoo developmentofdifferentiatinginfectedfromvaccinatedanimalsdivarealtimepcrforafricanhorsesicknessvirusserotype1